Councils - Basic Science and Translational Research
SCIENTIFIC COUNCIL ON BASIC SCIENCE AND TRANSLATIONAL RESEARCH Council Leadership Operating Board:COUNCIL CHAIR:
April 15-18, 2015
Nice, FRANCECarla C Baan, PhD
, Rotterdam, THE NETHERLANDSHoward J. Eisen, MD, FAHA, FACC, FACP
, Philadelphia, PA, USAStephan M. Ensminger, MD, DPhil
, Bad Oeynhausen, GERMANYLori J. West, MD, DPhil
, Edmonton, Alberta, CANADA
for more details.
Wednesday, April 9, 20142014 Basic Science and Translational Research Core Competency Curriculum
University of Missouri
Kansas City, Missouri, USAkgandy@mac.comKimberly Gandy, MD, PhD is an Associate Professor at the University of Missouri-Kansas City. Her primary area of basic and translational interest includes cellular therapy for tolerance induction using hematopoietic stem cells and myeloid progenitors. She is most recently involved in several translational projects regarding the use of mobile medical software for improving adherence in transplantation patients. Dr. Gandy earned her MD at Northwestern University in Evanston, Illinois, and her PhD in Immunology at Stanford University in Palo Alto, California. She completed general surgery and cardiovascular surgery residencies at Duke University Medical Center, and completed a cardiothoracic surgery postdoctoral research fellowship and pediatric cardiovascular surgery fellowship at Stanford University School of Medicine.COUNCIL VICE CHAIR:
Transplant and Stem Cell Immunobiology Lab (TSI)
Stanford, CA, USAschrepfer@stanford.eduSonja Schepfer, MD, PhD is Director of the Transplant and Stem Cell Immunobiology (TSI)-Lab at the University Heart Center in Hamburg, Germany. She is also a Visiting professor of CT Surgery at the Stanford University, School of Medicine. Her laboratory investigates experimental cardiac and lung transplantation, myocardial restoration, and vascular biology and her specific area of interest is translational research of stem cell immunobiology and solid organ transplantation. She graduated in Medicine in 2002 at the Universities Wuerzburg and Munich (Germany) and received her PhD in Immunology in 2007. She completed her postdoctoral fellowship in CT Surgery at Stanford University and started the CT Surgery Transplant Immunobiology group in 2007. Dr. Schrepfer received numerous awards for her research in the field of transplant and stem cell immunology, including the "Norman E Shumway Career Development Award" in 2010 from the ISHLT, the "Rudolf Pichlmayr Award" in 2007 from the German Transplant Society,and the "DFG Heisenberg W3-Professorship" in 2009; more information is available at www.TSI-lab.de.SENIOR ADVISORS:
University of Minnesota
Minneapolis, Minnesota, USA
firstname.lastname@example.orgBio coming soon...
University of Michigan
Ann Arbor, Michigan, USAplattjl@umich.eduJeffrey L. Platt, M.D. directs the Transplantation Biology Program and serves as Professor of Surgery, and Professor of Microbiology and Immunology at the University of Michigan. He investigates how T cells and B cells and their products interact with tissues to cause disease and to induce protection against further injury, how novel approaches might be used to replace organ function and restore immunological fitness and how fusion of one cell with another impacts on genomic integrity and cellular function. Dr. Platt is trained in Pediatrics (Childrens Hospital of LA) and nephrology (Univ Minnesota) and is a member of long standing of the ASN, AHA, the Association of American Physicians, IOM and the ISHLT.COUNCIL WORKFORCE LEADERS:
University of Michigan Medical School
Ann Arbor, MI, USA
email@example.comBio coming soon...
Drexel University College of Medicine and Hahnemann University Hospital
Philadelphia, PA, USA
215-762-5080Howard.Eisen@DrexelMed.eduDr. Eisen obtained his MD from the University of Pennsylvania (UPenn) School of Medicine in 1981 where he was elected to Alpha Omega Alpha. He completed his internal medicine residency at the Hospital of UPenn (1981-1984), followed by a fellowship in cardiovascular medicine at Washington Univ in St. Louis and Barnes Hospital (1984-87) where he received training in the management of cardiac transplant recipients. He subsequently was on the faculty of UPenn School of Medicine and Temple Univ before joining the Drexel Univ College of Medicine and Hahnemann Univ Hospital as Chief of the Division of Cardiology in 2005. Dr. Eisen has been funded by the NIH to study microchimerism and cell adhesion molecule expression in cardiac transplant rejection and has played an important role in the investigation of gene expression profiling in cardiac transplantation. Dr. Eisen is board certified in Internal Medicine, Cardiovascular Diseases and Advanced Heart Failure and Transplant Cardiology by the American Board of Internal Medicine.
University of Alberta
Edmonton, Alberta, CANADA
firstname.lastname@example.orgBio coming soon...
Yale New Haven Hospital
New Haven, CT, USA
email@example.comAs a physician-scientist and transplant immunologist, Dr. Goldstein examines how the innate immune system, in particular Toll-like receptors, impact alloimmunity and transplant tolerance. His work as a board certified transplant cardiologist affords him insights into whether preclinical immunological studies are relevant to solid organ transplantation. In addition, his research involves studies on how aging impacts innate immunity and the role of aging on alloimmmunity. In particular, his laboratory has discovered new pathways by which aging alters inflammation during acute viral infections, atherosclerosis, and information that age-induced inflammatory responses impact the tempo of acute allograft rejection and transplant tolerance.
Drexel University College of Medicine and Hahnemann University Hospital
Philadelphia, PA, USA
Heart Center North-Rhine Westphalia
Bad Oeynhausen, GERMANY
firstname.lastname@example.orgBio coming soon...
The Proof Centre of Excellence
email@example.comZsuzsanna Hollander is currently pursuing a PhD at UBC, Department of Pathology and Laboratory Medicine, under the supervision of Dr. Bruce McManus. Her work focuses on identifying novel biomarkers for the management of heart failure and heart transplant patients. Zsuzsa obtained a Masterís of Science degree in Computer Science from the University of British Columbia, Vancouver. She is also a certified Project Management Professional (PMP). Zsuzsa started working for the Biomarkers in Transplantation project in 2004 and transferred to the PROOF Centre of Excellence in 2008. She has expertise in genomics, proteomics and metabolomics data analyses as well as bioinformatics and data management.
UT Southwestern Medical Center
Dallas, Texas, USA
firstname.lastname@example.orgJ. Michael DiMaio, MD, is the Director of Cardiovascular and Thoracic Surgery Research and holds the Laurence and Susan Hirsch/Centex Distinguished Chair in Heart Disease at UT Southwestern Medical Center, and is the Surgical Director of the UT Southwestern Lung and Heart/Lung Transplant Programs. Dr. DiMaio received his medical degree from the University of Miami in 1987 and completed his internal medicine, general surgery and thoracic surgery residencies at Duke University Medical Center. While at Duke, Dr. DiMaio completed a surgical research fellowship focused on gene therapy, immunology, and transplantation. He joined the faculty at UTSW in 1998. Dr. DiMaio currently oversees clinical research projects focused on cardiac and thoracic research and has an active laboratory studying the effects of protein and pharmacologic agents involved with myocardial and neurological recovery. His clinical interests include transplantation, cardiac surgery, ventricular aneurysm repair, aortic stenting, minimally invasive and robotic cardiac and thoracic surgery, and the usage of Holmium-YAG laser therapy for tracheal and thoracic obstructive processes.
Alfred/Deakin Nursing Research Center
Melbourne, Victoria, AUSTRALIA
email@example.comAssociate Professor Judy Currey coordinates ten critical care and perioperative postgraduate nursing programs at Deaking University, Melbourne Australia. In 2011 Judy was awarded an Australian Learning and Teaching Council citation for Outstanding Contributions to Student Learning. In 2010 Judy was awarded four teaching and innovation awards including the Deakin University Teacher of the Year. At The Alfred/Deakin Nursing Research Centre, Judy's research program is focused on nurses' decision making to optimize recovery after critical illness (heart and lung transplantation), medication quality and safety, and the impact of health technologies (MCS) on patient outcomes and careers. Judy also researches teaching and assessment methods to improve graduate's skills, knowledge and attributes in critical care nurses and is an international expert in Team-Based Learning.
Lucile Salter Packard Children's Hospital
Palo Alto, California, USA
firstname.lastname@example.orgBio coming soon...
Los Angeles, CA, USA
email@example.comTam Khuu is the Clinical Pharmacist for the Advanced Heart Failure/Mechanical Support/Heart Transplant Program at the Ronald Reagan UCLA Medical Center in Los Angeles, California. In addition to clinical services, she plays an active role in education of fellows, residents, and students. Dr. Khuu has authored several articles in the areas of therapeutic drug monitoring, immunosuppression pharmacology, and infectious disease. Dr. Khuu received her pharmacy training at the University of California, San Francisco and completed her residency training at City of Hope in Duarte, California. She is Board Certified in Pharmacotherapy.
The Prince Charles Hospital
Brisbane, Queensland, AUSTRALIA
61-7-31394000Daniel_Chambers@health.qld.gov.auDan Chambers, MBBS MRCP FRACP MD, is a Thoracic and Transplant Physician and Head of Research in the Queensland Lung Transplant Service, Prince Charles Hospital, Brisbane, Australia. He is also Associate Professor in the School of Medicine, University of Queensland, and Deputy Chair of the Metropolitan North Human Research and Ethics Committee. He is a member of the Lung Standing Committee for the Transplantation Society of Australia and New Zealand, and the Research Subcommittee for the Thoracic Society of Australia and New Zealand. His main research interests include the pathogenesis of chronic lung allograft dysfunction, early detection of lymphocytic bronchiolitis, lung metagenomics, adult lung disease complicating extreme preterm birth and cell therapy for advanced lung disease.